$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] UPLC-MS/MS-based profiling of 31 neurochemicals in the mouse brain after treatment with the antidepressant nefazodone 원문보기

Microchemical journal, v.169, 2021년, pp.106580 -   

Kim, Seong Soon (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology) ,  Lee, Ha-Yeon (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology) ,  Song, Jin Sook (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology) ,  Bae, Myung-Ae (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology) ,  Ahn, Sunjoo (Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology)

Abstract AI-Helper 아이콘AI-Helper

Abstract Depression, typically understood as a mental disorder, is characterized by monoamine neurotransmitter deficiencies in the central nervous system (CNS). A majority of antidepressants have been developed to increase endogenous levels of monoamine neurotransmitters, such as dopamine (DA), nor...

Keyword

참고문헌 (55)

  1. 10.1111/j.1749-6632.1957.tb40753.x B.B. Brodie, P.A. Shore, A concept for a role of serotonin and norepinephrine as chemical mediators in the brain, Annals of the New York Academy of Sciences, 66 (1957) 631-642. 

  2. 10.1126/science.127.3296.471-a A. Carlsson, M. Lindqvist, T. Magnusson, B. Waldeck, On the presence of 3-hydroxytyramine in brain, Science, 127 (1958) 471-471. 

  3. 10.1093/oxfordjournals.bmb.a073622 W. Feldberg, The role of acetylcholinein the central nervous system, British medical bulletin, 6 (1950) 312-321. 

  4. J. Biol. Chem. Roberts 187 1 55 1950 10.1016/S0021-9258(19)50929-2 γ-Aminobutyric acid in brain: its formation from glutamic acid 

  5. Neuron Südhof 80 3 675 2013 10.1016/j.neuron.2013.10.022 Neurotransmitter release: the last millisecond in the life of a synaptic vesicle 

  6. 10.1101/cshperspect.a005637 T.C. Sudhof J. Rizo Synaptic vesicle exocytosis Cold Spring Harbor perspectives in biology 3 12 2011 a005637 a5637. 

  7. Science Snyder 224 22 1984 10.1126/science.6322304 Drug and neurotransmitter receptors in the brain 

  8. J. Neurochem. Fonnum 42 1 1984 10.1111/j.1471-4159.1984.tb09689.x Glutamate: a neurotransmitter in mammalian brain 

  9. Brain Res. Rev. Blokland 21 285 1995 10.1016/0165-0173(95)00016-X Acetylcholine: a neurotransmitter for learning and memory? 

  10. Acta Neurobiol. Exp. Arias-Carrión 2007 10.55782/ane-2007-1664 Dopamine, learning, and reward-seeking behavior 

  11. W. Danysz, C.G. Parsons, I. Bresink, G. Quack, Glutamate in CNS disorders, Drug News and Perspectives, 8 (1995) 261-261. 

  12. Neuropsychiatr. Dis. Treat. Nuss 11 165 2015 Anxiety disorders and GABA neurotransmission: a disturbance of modulation 

  13. Biol. Psychiatry Olney 26 5 505 1989 10.1016/0006-3223(89)90072-3 Excitatory amino acids and neuropsychiatrie disorders 

  14. Psychopharmacology McEntee 103 2 143 1991 10.1007/BF02244194 Serotonin, memory, and the aging brain 

  15. J. Neurochem. Palmer 48 1 8 1987 10.1111/j.1471-4159.1987.tb13120.x Presynaptic serotonergic dysfunction in patients with Alzheimer's disease 

  16. The Lancet Turecki 387 1227 2016 10.1016/S0140-6736(15)00234-2 Suicide and suicidal behaviour 

  17. Organization 2017 Depression and other common mental disorders: global health estimates 

  18. Mol. Psychiatry Hoertel 20 6 718 2015 10.1038/mp.2015.19 Mental disorders and risk of suicide attempt: a national prospective study 

  19. CNS Drug Rev. Skolnick 12 123 2006 10.1111/j.1527-3458.2006.00123.x Preclinical and clinical pharmacology of DOV 216,303, a “triple” reuptake inhibitor 

  20. Neuropsychiatr. Dis. Treat. Moret 7 9 2011 The importance of norepinephrine in depression 

  21. Curr. Neuropharmacol. Marks 6 338 2008 10.2174/157015908787386078 Triple reuptake inhibitors: the next generation of antidepressants 

  22. J. Psychiatr. Res. Herrera-Guzmán 43 855 2009 10.1016/j.jpsychires.2008.10.015 Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder 

  23. Pharmacol. Ther. Haenisch 129 352 2011 10.1016/j.pharmthera.2010.12.002 Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters 

  24. BMC psychiatry Jakobsen 17 58 2017 10.1186/s12888-016-1173-2 Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis 

  25. Mol. Psychiatry Hieronymus 21 523 2016 10.1038/mp.2015.53 Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression 

  26. Eur. J. Pharmacol. Dhir 568 177 2007 10.1016/j.ejphar.2007.04.028 Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor 

  27. J. Pharmacol. Exp. Ther. Cryan 295 1120 2000 Antidepressant-like behavioral effects mediated by 5-hydroxytryptamine2C receptors 

  28. Behav. Brain Res. Chenu 172 256 2006 10.1016/j.bbr.2006.05.011 Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test 

  29. Nature Kanof 272 329 1978 10.1038/272329a0 Brain histamine receptors as targets for antidepressant drugs 

  30. Neuropsychopharmacology Jensen 33 2303 2008 10.1038/sj.npp.1301646 N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT 1A agonist, as a putative mediator of quetiapine's antidepressant activity 

  31. Eur. J. Pharmacol. D'Aquila 405 365 2000 10.1016/S0014-2999(00)00566-5 The role of dopamine in the mechanism of action of antidepressant drugs 

  32. J. Chromatogr. B Bergh 1028 120 2016 10.1016/j.jchromb.2016.06.011 Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC-MS/MS 

  33. J. Chromatogr. B Zhao 995 15 2015 10.1016/j.jchromb.2015.05.017 Simultaneous determination of amino acid and monoamine neurotransmitters in PC12 cells and rats models of Parkinson’s disease using a sensitizing derivatization reagent by UHPLC-MS/MS 

  34. J. Chromatogr. B Patel 818 269 2005 10.1016/j.jchromb.2005.01.008 Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection 

  35. J. Pharm. Biomed. Anal. Han 2019 10.1016/j.jpba.2019.06.043 Development of an underivatized LC-MS/MS method for quantitation of 14 neurotransmitters in rat hippocampus, plasma and urine: Application to CUMS induced depression rats 

  36. Psychopharmacology Lin 233 3223 2016 10.1007/s00213-016-4359-x Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice 

  37. Neuropsychobiology Pompili 77 23 2019 10.1159/000491604 Tryptophan and kynurenine metabolites: are they related to depression? 

  38. J. Neural Transm. Myint 119 245 2012 10.1007/s00702-011-0741-3 The role of the kynurenine metabolism in major depression 

  39. Ann. N. Y. Acad. Sci. Paul 1003 250 2003 10.1196/annals.1300.016 Glutamate and depression: clinical and preclinical studies 

  40. Am. J. Psychiatry Abdallah 171 1320 2014 10.1176/appi.ajp.2014.14010067 Glutamate metabolism in major depressive disorder 

  41. Depression and anxiety Kalueff 24 495 2007 10.1002/da.20262 Role of GABA in anxiety and depression 

  42. Am. J. Psychiat. Gelenberg 1980 Tyrosine for the treatment of depression 

  43. Israel J. Psychiat. Relat. Sci. Oxenkrug 47 56 2010 Tryptophan-kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later 

  44. J. Neurol. Neurosurg. Psychiatry Curzon 33 698 1970 10.1136/jnnp.33.5.698 Tryptophan metabolism in depression 

  45. J. Chromatogr. A El-Sherbeni 1627 2020 10.1016/j.chroma.2020.461403 Addressing the instability issue of dopamine during microdialysis: the determination of dopamine, serotonin, methamphetamine and its metabolites in rat brain 

  46. J. Chromatogr. B Santos-Fandila 1001 191 2015 10.1016/j.jchromb.2015.07.040 Analysis of 17 neurotransmitters, metabolites and precursors in zebrafish through the life cycle using ultrahigh performance liquid chromatography-tandem mass spectrometry 

  47. Br. J. Pharmacol. Nacca 125 1617 1998 10.1038/sj.bjp.0702251 Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodents 

  48. Life Sci. Owens 57 24 PL373 1995 10.1016/0024-3205(95)02222-5 The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies 

  49. Psychopharmacology Meyer 144 279 1999 10.1007/s002130051004 The effects of single dose nefazodone and paroxetine upon 5-HT2A binding potential in humans using [18F]-setoperone PET 

  50. Alcohol Olausson 15 77 1998 10.1016/S0741-8329(97)00101-8 Nefazodone attenuates the behavioral and neurochemical effects of ethanol 

  51. J. Neurochem. Fryer 72 1117 1999 10.1046/j.1471-4159.1999.0721117.x Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function 

  52. Mol. Psychiatry Shytle 7 6 525 2002 10.1038/sj.mp.4001035 Nicotinic acetylcholine receptors as targets for antidepressants 

  53. J. Multidiscipl. Healthcare Di Pierro 8 39 2015 10.2147/JMDH.S77766 Role of betaine in improving the antidepressant effect of S-adenosyl-methionine in patients with mild-to-moderate depression 

  54. Mol. Psychiatry Luscher 16 4 383 2011 10.1038/mp.2010.120 The GABAergic deficit hypothesis of major depressive disorder 

  55. Front. Cell. Neurosci. Fogaça 13 87 2019 10.3389/fncel.2019.00087 Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD(Hybrid)

저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로